{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T04:05:20Z","timestamp":1792209920314,"version":"4.4.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K08134"],"award-info":[{"award-number":["22K08134"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-cardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jjcc.2024.11.004","type":"journal-article","created":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T11:48:04Z","timestamp":1732794484000},"page":"433-439","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Effect of tafamidis therapy on physical function in patients with wild-type transthyretin cardiac amyloidosis"],"prefix":"10.1016","volume":"85","author":[{"given":"Atsushi","family":"Shibata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Izumiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshitake","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Tanihata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoko","family":"Kitada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichiro","family":"Otsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asahiro","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiju","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jjcc.2024.11.004_bb0005","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1080\/13506129.2018.1549825","article-title":"Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee","volume":"25","author":"Benson","year":"2018","journal-title":"Amyloid"},{"key":"10.1016\/j.jjcc.2024.11.004_bb0010","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jjcc.2017.10.003","article-title":"Recent advances in diagnosis and treatment of cardiac amyloidosis","volume":"71","author":"Izumiya","year":"2018","journal-title":"J Cardiol"},{"key":"10.1016\/j.jjcc.2024.11.004_bb0015","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1093\/eurheartj\/ehv338","article-title":"Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction","volume":"36","author":"Gonz\u00e1lez-L\u00f3pez","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2024.11.004_bb0020","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0002-9343(96)00229-X","article-title":"The premortem recognition of systemic senile amyloidosis with cardiac involvement","volume":"101","author":"Kyle","year":"1996","journal-title":"Am J Med"},{"key":"10.1016\/j.jjcc.2024.11.004_bb0025","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1001\/archinte.165.12.1425","article-title":"Senile systemic amyloidosis presenting with heart failure: a comparison with light chain-associated amyloidosis","volume":"165","author":"Ng","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jjcc.2024.11.004_bb0030","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1161\/CIRCULATIONAHA.115.018852","article-title":"Heart failure resulting from age-related cardiac amyloid disease associated with wild-type transthyretin: a prospective, observational cohort study","volume":"133","author":"Connors","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2024.11.004_bb0035","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jacc.2016.06.033","article-title":"Natural history of wild-type transthyretin cardiac amyloidosis and risk stratification using a novel staging system","volume":"68","author":"Grogan","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2024.11.004_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbapap.2004.09.023","article-title":"Interactions amongst plasma retinol-binding protein, transthyretin and their ligands: implications in vitamin A homeostasis and transthyretin amyloidosis","volume":"1703","author":"Raghu","year":"2004","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jjcc.2024.11.004_bb0045","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.116.003815","article-title":"Design and rationale of the phase 3 ATTR-ACT clinical trial (Tafamidis in Transthyretin Cardiomyopathy Clinical Trial)","volume":"10","author":"Maurer","year":"2017","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jjcc.2024.11.004_bb0050","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2024.11.004_bb0055","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.healun.2003.10.002","article-title":"Heart failure survival score continues to predict clinical outcomes in patients with heart failure receiving beta-blockers","volume":"23","author":"Koelling","year":"2004","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jjcc.2024.11.004_bb0060","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1161\/01.CIR.85.5.1751","article-title":"Alterations of skeletal muscle in chronic heart failure","volume":"85","author":"Drexler","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2024.11.004_bb0065","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0002-9149(99)00497-X","article-title":"Comparison of usefulness between exercise capacity and echocardiographic indexes of left ventricular function in cardiac amyloidosis","volume":"84","author":"Trikas","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jjcc.2024.11.004_bb0070","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1002\/ehf2.13538","article-title":"Increased oxidative stress during exercise predicts poor prognosis in patients with acute decompensated heart failure","volume":"8","author":"Shibata","year":"2021","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jjcc.2024.11.004_bb0075","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1152\/jappl.1986.60.6.2020","article-title":"A new method for detecting anaerobic threshold by gas exchange","volume":"60","author":"Beaver","year":"1986","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.jjcc.2024.11.004_bb0080","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/S0735-1097(96)00412-3","article-title":"Oxygen uptake efficiency slope: a new index of cardiorespiratory functional reserve derived from the relation between oxygen uptake and minute ventilation during incremental exercise","volume":"28","author":"Baba","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2024.11.004_bb0085","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.echo.2016.01.011","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"29","author":"Nagueh","year":"2016","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.jjcc.2024.11.004_bb0090","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","article-title":"Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan","volume":"53","author":"Matsuo","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jjcc.2024.11.004_bb0095","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1253\/circj.CJ-21-0965","article-title":"Early experience of tafamidis treatment in Japanese patients with wild-type transthyretin cardiac amyloidosis from the Kochi Amyloidosis Cohort","volume":"86","author":"Ochi","year":"2022","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2024.11.004_bb0100","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1002\/ejhf.2974","article-title":"Improved long-term survival with tafamidis treatment in patients with transthyretin amyloid cardiomyopathy and severe heart failure symptoms","volume":"25","author":"Elliott","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jjcc.2024.11.004_bb0105","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1253\/circj.CJ-22-0683","article-title":"Impact of tafamidis on echocardiographic cardiac function of patients with transthyretin cardiac amyloidosis","volume":"87","author":"Ichikawa","year":"2023","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2024.11.004_bb0110","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/ejhf.899","article-title":"Inotropic myocardial reserve deficiency is the predominant feature of exercise haemodynamics in cardiac amyloidosis","volume":"19","author":"Clemmensen","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jjcc.2024.11.004_bb0115","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s00380-023-02342-w","article-title":"Elevation of end-tidal CO2 during exercise is attenuated in patients with cardiac amyloidosis","volume":"39","author":"Shibata","year":"2024","journal-title":"Heart Vessels"},{"key":"10.1016\/j.jjcc.2024.11.004_bb0120","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.amjcard.2020.10.066","article-title":"Impact of tafamidis on health-related quality of life in patients with transthyretin amyloid cardiomyopathy (from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial)","volume":"141","author":"Hanna","year":"2021","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jjcc.2024.11.004_bb0125","doi-asserted-by":"crossref","first-page":"204","DOI":"10.4103\/atm.ATM_364_16","article-title":"Pulmonary consequences of hypothyroidism","volume":"12","author":"Sadek","year":"2017","journal-title":"Ann Thorac Med"}],"container-title":["Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S091450872400217X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S091450872400217X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T02:10:01Z","timestamp":1780279801000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S091450872400217X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S091450872400217X"],"URL":"https:\/\/doi.org\/10.1016\/j.jjcc.2024.11.004","relation":{},"ISSN":["0914-5087"],"issn-type":[{"value":"0914-5087","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of tafamidis therapy on physical function in patients with wild-type transthyretin cardiac amyloidosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jjcc.2024.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Japanese College of Cardiology. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}